Albumin-DX Lipid-Reduced- recombinant human albumin for diagnostics
:
10g ($250)
100g ($2,000)


Albumin-DX Reduces non-specific binding, improves specificity, consistent, outperforms BSA and pHSA, regulatory friendly, enhances stability.

Albumin DX-Lipid Reduced – Recombinant albumin diagnostic blocking reagent.

Albumin DX-LR reduces non-specific binding and cross reactivity, enhances biomarker stability and is free of any immunoglobulin or proteases.

Serum albumin is a common blocking reagent used in diagnostic applications. Since Albumin DX-LR is recombinant albumin produced in a completely animal-free system, it is immunoglobulin and protease free. This reduces non-specific binding and cross reactivity thus improving specificity and reproducible results. In addition, Albumin DX-LR improves the stability of antibodies and analytes. Unlike bovine albumin or human serum albumin, Albumin DX-LR is a consistent reagent with no lot-to-lot variability or concerns about occupational safety, which arise with animal or human blood products. Being an animal and human free product also eliminates additional regulatory requirements associated with the import or export of blood products.

Research has shown that Albumin DX-LR outperforms both bovine albumin and human serum albumin and is a cost-effective way to improve diagnostic performance.

Advantages

  • Reduces non-specific binding and cross reactivity
  • Recombinant, consistent product
  • Enhances stability of antibodies and analytes
  • Immunoglobulin free
  • Protease free
  • Outperforms bovine albumin and human serum albumin

Comparative Data

Albumin-DX improves stability better than commercial diluent

Albumin-DX Lipid-Reduced showed more stable biomarker activity over 96 hours compared to a commercial diluent.

For more information, please call 1-800-916-8311 or email us

Product Technical Documents:


pdf-icon Product Specifications


Other Documents:


pdf-icon Brochure: Albumin-DX LR (Lipid Reduced)
 

 



Invitria Cart   Your Cart is currently empty.